Barings LLC lifted its stake in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 11.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 56,588 shares of the company’s stock after acquiring an additional 5,862 shares during the quarter. Barings LLC’s holdings in Express Scripts were worth $4,369,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in ESRX. Kaizen Advisory LLC raised its holdings in Express Scripts by 147.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock valued at $104,000 after buying an additional 800 shares during the period. Adviser Investments LLC raised its holdings in Express Scripts by 321.9% during the 2nd quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock valued at $114,000 after buying an additional 1,130 shares during the period. Wealthcare Advisory Partners LLC raised its holdings in Express Scripts by 364.7% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,529 shares of the company’s stock valued at $106,000 after buying an additional 1,200 shares during the period. Migdal Insurance & Financial Holdings Ltd. raised its holdings in Express Scripts by 3,048.1% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,637 shares of the company’s stock valued at $126,000 after buying an additional 1,585 shares during the period. Finally, CKW Financial Group purchased a new stake in Express Scripts during the 2nd quarter valued at $154,000. Institutional investors own 84.71% of the company’s stock.
Shares of ESRX traded down $0.24 during midday trading on Friday, reaching $88.02. 3,209,300 shares of the stock were exchanged, compared to its average volume of 4,299,910. Express Scripts Holding Co has a 52 week low of $55.80 and a 52 week high of $89.60. The company has a current ratio of 0.71, a quick ratio of 0.59 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $49.52 billion, a price-to-earnings ratio of 12.40, a PEG ratio of 1.11 and a beta of 0.95.
Several research firms recently weighed in on ESRX. Royal Bank of Canada increased their price target on Express Scripts to $94.00 and gave the company an “outperform” rating in a report on Monday. BidaskClub upgraded Express Scripts from a “sell” rating to a “hold” rating in a report on Tuesday, July 31st. Zacks Investment Research lowered Express Scripts from a “hold” rating to a “sell” rating in a report on Monday, July 23rd. William Blair upgraded Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Finally, Robert W. Baird downgraded Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 price objective on the stock. in a research report on Friday, July 20th. Three research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $85.58.
In related news, insider Christine Houston sold 10,000 shares of the company’s stock in a transaction on Wednesday, June 13th. The stock was sold at an average price of $82.28, for a total transaction of $822,800.00. Following the completion of the sale, the insider now directly owns 108,010 shares in the company, valued at approximately $8,887,062.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.79% of the company’s stock.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Story: Marijuana Stocks Investing Considerations
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.